Müller-Dott, S., Jaehnig, E. J., Munchic, K. P., Jiang, W., Yaron-Barir, T. M., Savage, S. R., Garrido-Rodriguez, M., Johnson, J. L., Lussana, A., Petsalaki, E., Lei, J. T., Dugourd, A., Krug, K., Cantley, L. C., Mani, D. R., Zhang, B., & Saez-Rodriguez, J. (2025). Comprehensive evaluation of phosphoproteomic-based kinase activity inference. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-59779-y

Williams, G. P., Freuchet, A., Michaelis, T., Frazier, A., Tran, N. K., Rodrigues Lima-Junior, J., Phillips, E. J., Mallal, S. A., Litvan, I., Goldman, J. G., Alcalay, R. N., Sidney, J., Sulzer, D., Sette, A., & Lindestam Arlehamn, C. S. (2024). PINK1 is a target of T cell responses in Parkinson’s disease. Journal of Clinical Investigation. https://doi.org/10.1172/jci180478

Zhu, Y., Jiang, W., Lee, B. J., Li, A., Gershik, S., & Zha, S. (2023). Phosphorylation of DNA-PKcs at the S2056 cluster ensures efficient and productive lymphocyte development in XLF-deficient mice. Proceedings of the National Academy of Sciences, 120(25). https://doi.org/10.1073/pnas.2221894120

Hu, J., Waters, C. H., Spiegelman, D., Fon, E. A., Yu, E., Asayesh, F., Krohn, L., Saini, P., Alcalay, R. N., Hassin-Baer, S., Gan-Or, Z., Krainc, D., Zhang, B., Bustos, B. I., & Lubbe, S. J. (2022). Gene-based burden analysis of damaging private variants in PRKN, PARK7 and PINK1 in Parkinson’s disease cohorts of European descent. Neurobiology of Aging, 119, 136–138. https://doi.org/10.1016/j.neurobiolaging.2022.07.012

Appunni, S., Gupta, D., Rubens, M., Ramamoorthy, V., Singh, H. N., & Swarup, V. (2021). Deregulated Protein Kinases: Friend and Foe in Ischemic Stroke. Molecular Neurobiology, 58(12), 6471–6489. https://doi.org/10.1007/s12035-021-02563-y